Categories: Technology

Invitation 2026 Half-Year Results Conference for Analysts and Investors

Ladies and Gentlemen,

We invite you to the Ascom Holding Ltd Analyst and Investor Conference on the occasion of the publication of the 2026 half-year results:

Date: Wednesday, 29 July 2026
Start: 10:00 a.m. CEST
Format: Online, via Microsoft Teams
Speakers: David Hale, CEO; Kalina Scott, CFO

Video webinar with Q&A session
The conference will be streamed via Microsoft Teams. The conference will be conducted in English.
Please use the following link to join.

Microsoft Teams Meeting: Link
Meeting ID: 314 619 521 920 748
Passcode: Qf7Ng2Yq

Dial in by phone: +41 43 216 35 11
Phone conference ID: 107264094#

If you are joining via smartphone, please download the Teams app in advance. Please dial in five minutes before the start.
Following the presentation, participants can ask questions live or in writing via chat during the Q&A session.

Ascom will publish the press release, the presentation, and the 2026 Half-Year Report on July 29, 2026, at 7:00 a.m. CEST on www.ascom.com.

Best regards,
Kalina Scott
CFO

GlobeNews Wire

Recent Posts

Virtune Adds BitGo as an Additional Custodian for Selected ETPs Within Its ETP Programme

Stockholm, 13 July 2026 – Virtune today announces that the issuer has added an additional…

1 hour ago

Lleida.net records 791 new customer sign-ups in June, a record high

Madrid, 13 July.—The listed technology services company Lleida.net (BME:LLN, EPA:ALLLN) recorded 791 new customer sign-ups…

1 hour ago

Irvinder Singh Lail Named to Lead J.S. Held Global Capability

Enterprise role focused on scaling talent, accelerating client response, and expanding operational capacity across the…

4 hours ago

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

The new data demonstrates the potential to improve control of acute infection, latency, and viral…

13 hours ago

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

July 12, 2026 06:28 ET  | Source: Hemab Therapeutics, Inc. HMB-002 clinical data demonstrate proof…

13 hours ago